PUS1 and metabolic dysfunction-associated steatotic liver disease: PUS1 may also be involved in metabolic pathways, mitochondrial function, nonalcoholic fatty liver disease (NAFLD), and important oncogenic pathways and can be used as a clinical diagnostic biomarker for sepsis [121, 122].